Podcast 31: Making your clinical life easier — with genetics. Dr. Julie Johnson talks about using a patient’s genetic profile to help set their initia...

Starting a patient on warfarin is nobody’s idea of a good time, but pharmacogenetic research can help. A study in this week’s NEJM shows the advantage of using genetic information (plus some clinical data) over the old “start at 5 mg a day and pray for success” approach. We talk with Julie Johnson of the University of Florida about the study. We’ve shortened our news presentation, on the theory that you can’t assimilate too many details through your ears, so we give you the aural cartoon version and provide links for details at the website: podcasts.jwatch.org. If you want to contact us with your suggestions, please call 1 617 440 4374. Links for this edition: Healthy Behaviors Associated with Halving of Stroke Risk Patients’ Genetic Profiles Help Determine Appropriate Warfarin Dosing Bypass Grafting Proves Superior to PCI in Severe Coronary Artery Disease Less Than 1% of U.S. Adolescents Need Drug Treatment for Dyslipidemia The post Podcast 31: Making your clinical life easier — with genetics. Dr. Julie Johnson talks about using a patient’s genetic profile to help set their initial warfarin dose more accurately. You got a problem with that? first appeared on Clinical Conversations.